Future research should further explore the efficacy of antidiabetic drugs on the motor symptoms of PD, investigate PD patients with higher severity, and assess the efficacy and safety of other non-GLP-1 agonist antidiabetic drugs. The gene discussed is GLP1R; the disease is Parkinson disease.